“A first-gen kid between cultures. A student learning medicine across continents. A young professional navigating insurance and finance. A doctor rediscovering purpose through patient care and policy. Every twist taught me a new way to see healthcare — and who it’s meant to

Cancer Care, Policy Realities, And Lessons From Abroad - Dr. Amar Rewari, MD - @DrAmarExplains - Chief, Radiation Oncology, @LuminisHealth @ProgressPotent1 @ASTRO_org @ValHealthVoices @DrAntoParavati @FEAScholarships @YaleMed @Yale @irat1onal @Triple7PR #RadiationOncology

Link to the full interview: https://t.co/RGHry5ISMQ #ProstateCancer #Oncology #CancerCare #radonc

Tools like Pluvicto and SBRT are expanding what coordinated care can achieve.

And it works with, not instead of, systemic therapy. “For advanced prostate cancer, radiation complements, not replaces, systemic therapy.”

“Radiation is one of the most effective ways to relieve pain from bone metastases… Most patients feel improvement within 1–2 weeks.”

Care is increasingly personalized with genomics, tumor biology, and patient goals.

Systemic therapy is the backbone. Many patients with mHSPC start with ADT plus agents like apalutamide or abiraterone.

Advanced prostate cancer care is changing quickly. I spoke with @PatientPower about how the focus is shifting toward long-term control and quality of life.

80% of cancer patients struggle with radiation-induced fatigue. This isn't just being tired—it's a profound exhaustion that impacts life. Why does it happen and how do we fight it? As I discuss in a new article: Full Link - https://t.co/1wyikRynPg Repair takes energy:

Honored to speak with @Independent about how Prior Authorization delays harm my cancer patients and overwhelm oncology practices. These stories are heartbreaking—and they reveal a dangerous truth: for patients with aggressive disease, insurance red tape can be life or death.

Protecting Our Code Set: New Codes for Superficial Radiation Therapy We're covering another major advocacy win: the creation of a new, dedicated code set for Superficial Radiation Therapy (SRT). While much attention has been paid to the new core RT Treatment Delivery codes,

The Efficiency Adjustment: A Closer Look at the 2.5% Cut In the third part of our series on the 2025 Medicare Physician Fee Schedule, we’re addressing a broad, controversial policy that impacts almost every proceduralist in medicine: the Efficiency Adjustment. This adjustment,

The Biggest Win in 20 Years: Radiation Oncology Payments Tied to HOPPS! In the second installment of our four-part series on the new RT Treatment Delivery Codes, we're diving into the final rule's most surprising and impactful proposal: the crosswalk to the Hospital Outpatient

The Real History Behind the New Treatment Delivery Codes One of the biggest changes in this year’s Medicare Physician Fee Schedule is the complete rebuild of our radiation treatment delivery codes. Many have asked how we reached this point, so this first post in a four part

I was honored to be interviewed for this new Oncology News Central story on how the 2026 Medicare Physician Fee Schedule will affect cancer care. https://t.co/IahCI4U6Gb Payment policy shapes everything we can deliver in oncology, so I appreciated the chance to speak candidly

STOP THE SHUTDOWN MADNESS! Washington is failing to govern, and YOU are paying the price! 🚨 A political standoff is threatening to raise health insurance premiums for millions while crippling medical innovation. In this explosive clip, we break down the perfect storm

A new blood test called Galleri claims to detect over 50 cancers from a single blood draw by looking for methylation signals on DNA bits shed by tumors. Experts are excited, as it can screen for cancers we currently lack tools for (like pancreatic, liver, and ovarian). But

I recently spoke with @PatientPower about IVIG therapy and why home-based infusions can be life-changing for some CLL patients. For many, being able to safely receive treatment at home means more comfort, flexibility, and fewer infection risks. “IVIG is made from antibodies